Mazars assists Livingstone Health Limited in the listing on the Catalist Board of the Singapore Exchange

On 8 February 2021, Livingstone Health Limited’s public shares were listed on the Catalist Board of the Singapore Exchange. Livingstone Health Limited is a Singapore-based multidisciplinary healthcare group whose core competencies include Aesthetics & Wellness, Anaesthesiology & Pain Management, Family Medicine, Internal Medicine and Orthopaedic Surgery.

About the project

This was the first Reverse Takeover (RTO) project for Mazars in Singapore. 

Livingstone Health Limited has 15 medical doctors practising at 12 medical clinics and 1 medical spa located at convenient and accessible locations throughout Singapore. In addition, the Group has also ventured into other paramedical products and services, such as physiotherapy. It has joint ventures to provide aesthetics and wellness services in Cambodia and also offers healthcare design consultancy services.

With Singapore’s healthcare industry recognised as one of the best in the world, together with SGX’s footprint and connectivity in the region, we look forward to supporting Livingstone Health in its efforts to tap on the rising growth opportunities in Asia.

Livingstone Health Limited's IPO was led by the following Mazars team, who worked closely together with the client to achieve this significant milestone: 

  • Rick Chan – Managing Partner
  • Chee Keong Ooi – Partner in Audit & Assurance
  • Zi En Wong – Senior Manager in Audit & Assurance